OE
GILD icon

October Effect’s Gilead Sciences GILD Stock Holding History

October Effect’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Sell
6,885
-100
-1% -$13.2K 0.82% 34
2026
Q1 		$973K Sell
6,985
-30
-0.4% -$4.2K 1.12% 31
2025
Q4 		$861K Hold
7,015
– – 0.95% 30
2025
Q3 		$779K Sell
7,015
-590
-8% -$67.1K 0.86% 26
2025
Q2 		$843K Buy
+7,605
New +$809K 1.02% 24

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

October Effect's GILD Position: Q2 2026 in Review

October Effect reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $13.2K and leaving 6,885 shares worth $870K. The position accounts for 0.82% of the portfolio, ranked #34.

October Effect first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $973K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • October Effect held 6,885 shares of Gilead Sciences worth $870K as of Q2 2026.
  • October Effect sold 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
  • Gilead Sciences made up 0.82% of October Effect's portfolio in Q2 2026, its #34 holding.
  • October Effect first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • October Effect's Gilead Sciences position peaked at $973K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on October Effect's 13F filing for Q2 2026, filed 21 Jul 2026.